Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mehta

Showing results (1071-1080 of 1,180) with videos related to

Pageof 118
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2019
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trialJulian Gold, Dominic B Rowe, Matthew C Kiernan, et al.
International Journal of Cardiology|November 22, 2016
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudyAkshay Bagai, Tracy Y Wang, Shaun G Goodman, et al.
Journal of the American College of Cardiology|May 14, 2021
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI TrialsLawrence A Leiter, Deepak L Bhatt, Darren K McGuire, et al.
Circulation|August 29, 2022
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical TrialsGiuseppe Gargiulo, Daniele Giacoppo, Sanjit S Jolly, et al.
Annals of Neurology|December 15, 2018
Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasiaKatherine Schon, Nienke J H van Os, Nicholas Oscroft, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 25, 2017
Identification of major routes of HIV transmission throughout MesoamericaAntoine Chaillon, Santiago Avila-Ríos, Joel O Wertheim, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Journal of the American College of Cardiology|November 6, 2025
Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized TrialShamir R Mehta, Natalia Pinilla-Echeverri, Denise Tiong, et al.
Lancet (London, England)|September 6, 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L Bhatt, Philippe Gabriel Steg, Shamir R Mehta, et al.
Pageof 118

Showing results (1071-1080 of 1,180) with videos related to

Sort By:
Pageof 118
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2019
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trialJulian Gold, Dominic B Rowe, Matthew C Kiernan, et al.
International Journal of Cardiology|November 22, 2016
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudyAkshay Bagai, Tracy Y Wang, Shaun G Goodman, et al.
Journal of the American College of Cardiology|May 14, 2021
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI TrialsLawrence A Leiter, Deepak L Bhatt, Darren K McGuire, et al.
Circulation|August 29, 2022
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical TrialsGiuseppe Gargiulo, Daniele Giacoppo, Sanjit S Jolly, et al.
Annals of Neurology|December 15, 2018
Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasiaKatherine Schon, Nienke J H van Os, Nicholas Oscroft, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 25, 2017
Identification of major routes of HIV transmission throughout MesoamericaAntoine Chaillon, Santiago Avila-Ríos, Joel O Wertheim, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Journal of the American College of Cardiology|November 6, 2025
Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized TrialShamir R Mehta, Natalia Pinilla-Echeverri, Denise Tiong, et al.
Lancet (London, England)|September 6, 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L Bhatt, Philippe Gabriel Steg, Shamir R Mehta, et al.
Pageof 118